Template:ICH Hypertension Guidelines - Revision history

Rossdonaldson1 at 19:43, 10 January 2015

2015-01-10T19:43:15Z

← Older revision		Revision as of 19:43, 10 January 2015
Line 1:		Line 1:
	{{AHA spontaneous ~~ICM~~ BP guidelines}}		{{AHA spontaneous ICH BP guidelines}}

	{{AHA SAH BP Guidelines}}		{{AHA SAH BP Guidelines}}

Rossdonaldson1: Replaced content with "{{AHA spontaneous ICM BP guidelines}} {{AHA SAH BP Guidelines}}"

2015-01-10T19:39:28Z

Replaced content with "{{AHA spontaneous ICM BP guidelines}} {{AHA SAH BP Guidelines}}"

← Older revision		Revision as of 19:39, 10 January 2015
Line 1:		Line 1:
	~~===~~AHA ~~Spontaneous ICH~~ BP Guidelines<ref>Morgenstern, L. et al. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association Stroke 2010;41;2108-2129 [http://bit.ly/ahaichguide PDF]</ref>===		{{AHA spontaneous ICM BP guidelines}}
	~~#If SBP is >200 mm Hg or MAP is >150 mm Hg, then consider aggressive reduction of BP with continuous intravenous infusion, with frequent BP monitoring every 5 min.~~
	#If SBP is >180 mmHg or MAP is >130mm Hg and there is the possibility of elevated ICP, then consider monitoring ICP and reducing BP using intermittent or continuous intravenous medications while maintaining a cerebral perfusion pressure ≥60 mm Hg
	#If SBP is >180 mmHg or MAP is >130 mmHg and there is not evidence of elevated ICP, then consider a modest reduction of BP '''(eg, MAP of 110 mm Hg or target BP of 160/90 mm Hg)''' using intermittent or continuous intravenous medications to control BP and clinically reexamine the patient every 15 min


	{{AHA SAH BP Guidelines}}		{{AHA SAH BP Guidelines}}

Ostermayer: /* AHA Aneurysmal SAH BP GuidelinesBederson J. et al. Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association. Stroke. ...

2014-07-22T01:16:14Z

/* AHA Aneurysmal SAH BP GuidelinesBederson J. et al. Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association. Stroke. ...

← Older revision		Revision as of 01:16, 22 July 2014
Line 5:		Line 5:


	~~===~~AHA ~~Aneurysmal~~ SAH BP Guidelines<ref>Bederson J. et al. Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association. Stroke. 2009;40:994-1025 [http://stroke.ahajournals.org/content/40/3/994.full.pdf PDF]</ref>===		{{AHA SAH BP Guidelines}}
	~~#To date, no well-controlled studies exist that answer whether blood pressure control in acute Aneurysmal Subarachnoid Hemorrhage influences rebreeding.~~
	#Blood pressure should be monitored and controlled to balance the risk of stroke, hypertension-related rebleeding, and maintenance of cerebral perfusion pressure (Class I, [[EBQ:Evidence_Levels\|Level of Evidence B]]).
	#Nicardipine, labetalol, and esmolol are appropriate choices for blood pressure control. Sodium nitroprusside may raise intracranial pressure and cause toxicity with prolonged infusion and should be avoided.

Ostermayer: /* AHA Aneurysmal SAH BP GuidelinesBederson J. et al. Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association. Stroke. ...

2014-05-23T14:54:23Z

← Older revision		Revision as of 14:54, 23 May 2014
Line 7:		Line 7:
	===AHA Aneurysmal SAH BP Guidelines<ref>Bederson J. et al. Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association. Stroke. 2009;40:994-1025 [http://stroke.ahajournals.org/content/40/3/994.full.pdf PDF]</ref>===		===AHA Aneurysmal SAH BP Guidelines<ref>Bederson J. et al. Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association. Stroke. 2009;40:994-1025 [http://stroke.ahajournals.org/content/40/3/994.full.pdf PDF]</ref>===
	#To date, no well-controlled studies exist that answer whether blood pressure control in acute Aneurysmal Subarachnoid Hemorrhage influences rebreeding.		#To date, no well-controlled studies exist that answer whether blood pressure control in acute Aneurysmal Subarachnoid Hemorrhage influences rebreeding.
	#Blood pressure should be monitored and controlled to balance the risk of stroke, hypertension-related rebleeding, and maintenance of cerebral perfusion pressure (Class I, [EBQ:Evidence_Levels\|Level of Evidence B]).		#Blood pressure should be monitored and controlled to balance the risk of stroke, hypertension-related rebleeding, and maintenance of cerebral perfusion pressure (Class I, [[EBQ:Evidence_Levels\|Level of Evidence B]]).
	#Nicardipine, labetalol, and esmolol are appropriate choices for blood pressure control. Sodium nitroprusside may raise intracranial pressure and cause toxicity with prolonged infusion and should be avoided.		#Nicardipine, labetalol, and esmolol are appropriate choices for blood pressure control. Sodium nitroprusside may raise intracranial pressure and cause toxicity with prolonged infusion and should be avoided.

Ostermayer: /* AHA Aneurysmal SAH BP GuidelinesBederson J. et al. Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association. Stroke. ...

2014-05-23T14:54:03Z

← Older revision		Revision as of 14:54, 23 May 2014
Line 7:		Line 7:
	===AHA Aneurysmal SAH BP Guidelines<ref>Bederson J. et al. Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association. Stroke. 2009;40:994-1025 [http://stroke.ahajournals.org/content/40/3/994.full.pdf PDF]</ref>===		===AHA Aneurysmal SAH BP Guidelines<ref>Bederson J. et al. Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association. Stroke. 2009;40:994-1025 [http://stroke.ahajournals.org/content/40/3/994.full.pdf PDF]</ref>===
	#To date, no well-controlled studies exist that answer whether blood pressure control in acute Aneurysmal Subarachnoid Hemorrhage influences rebreeding.		#To date, no well-controlled studies exist that answer whether blood pressure control in acute Aneurysmal Subarachnoid Hemorrhage influences rebreeding.
	#Blood pressure should be monitored and controlled to balance the risk of stroke, hypertension-related rebleeding, and maintenance of cerebral perfusion pressure (Class I, Level of Evidence B).		#Blood pressure should be monitored and controlled to balance the risk of stroke, hypertension-related rebleeding, and maintenance of cerebral perfusion pressure (Class I, [EBQ:Evidence_Levels\|Level of Evidence B]).
	#Nicardipine, labetalol, and esmolol are appropriate choices for blood pressure control. Sodium nitroprusside may raise intracranial pressure and cause toxicity with prolonged infusion and should be avoided.		#Nicardipine, labetalol, and esmolol are appropriate choices for blood pressure control. Sodium nitroprusside may raise intracranial pressure and cause toxicity with prolonged infusion and should be avoided.

Ostermayer: /* AHA Aneurysmal Subarachnoid Hemorrhage BP GuidelinesBederson J. et al. Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart A...

2014-05-21T16:23:47Z

/* AHA Aneurysmal Subarachnoid Hemorrhage BP GuidelinesBederson J. et al. Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart A...

← Older revision		Revision as of 16:23, 21 May 2014
Line 5:		Line 5:


	===AHA Aneurysmal ~~Subarachnoid Hemorrhage~~ BP Guidelines<ref>Bederson J. et al. Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association. Stroke. 2009;40:994-1025 [http://stroke.ahajournals.org/content/40/3/994.full.pdf PDF]</ref>===		===AHA Aneurysmal SAH BP Guidelines<ref>Bederson J. et al. Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association. Stroke. 2009;40:994-1025 [http://stroke.ahajournals.org/content/40/3/994.full.pdf PDF]</ref>===
	#To date, no well-controlled studies exist that answer whether blood pressure control in acute ~~SAH~~ influences rebreeding.		#To date, no well-controlled studies exist that answer whether blood pressure control in acute Aneurysmal Subarachnoid Hemorrhage influences rebreeding.
	#Blood pressure should be monitored and controlled to balance the risk of stroke, hypertension-related rebleeding, and maintenance of cerebral perfusion pressure (Class I, Level of Evidence B).		#Blood pressure should be monitored and controlled to balance the risk of stroke, hypertension-related rebleeding, and maintenance of cerebral perfusion pressure (Class I, Level of Evidence B).
	#Nicardipine, labetalol, and esmolol are appropriate choices for blood pressure control. Sodium nitroprusside may raise intracranial pressure and cause toxicity with prolonged infusion and should be avoided.		#Nicardipine, labetalol, and esmolol are appropriate choices for blood pressure control. Sodium nitroprusside may raise intracranial pressure and cause toxicity with prolonged infusion and should be avoided.

Ostermayer: /* AHA Spontaneous ICH Blood Pressure GuidelinesMorgenstern, L. et al. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association Strok...

2014-05-15T15:17:50Z

/* AHA Spontaneous ICH Blood Pressure GuidelinesMorgenstern, L. et al. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association Strok...

← Older revision		Revision as of 15:17, 15 May 2014
Line 1:		Line 1:
	===AHA Spontaneous ICH ~~Blood Pressure~~ Guidelines<ref>Morgenstern, L. et al. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association Stroke 2010;41;2108-2129 [http://bit.ly/ahaichguide PDF]</ref>===		===AHA Spontaneous ICH BP Guidelines<ref>Morgenstern, L. et al. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association Stroke 2010;41;2108-2129 [http://bit.ly/ahaichguide PDF]</ref>===
	#If SBP is >200 mm Hg or MAP is >150 mm Hg, then consider aggressive reduction of BP with continuous intravenous infusion, with frequent BP monitoring every 5 min.		#If SBP is >200 mm Hg or MAP is >150 mm Hg, then consider aggressive reduction of BP with continuous intravenous infusion, with frequent BP monitoring every 5 min.
	#If SBP is >180 mmHg or MAP is >130mm Hg and there is the possibility of elevated ICP, then consider monitoring ICP and reducing BP using intermittent or continuous intravenous medications while maintaining a cerebral perfusion pressure ≥60 mm Hg		#If SBP is >180 mmHg or MAP is >130mm Hg and there is the possibility of elevated ICP, then consider monitoring ICP and reducing BP using intermittent or continuous intravenous medications while maintaining a cerebral perfusion pressure ≥60 mm Hg
	#If SBP is >180 mmHg or MAP is >130 mmHg and there is not evidence of elevated ICP, then consider a modest reduction of BP '''(eg, MAP of 110 mm Hg or target BP of 160/90 mm Hg)''' using intermittent or continuous intravenous medications to control BP and clinically reexamine the patient every 15 min		#If SBP is >180 mmHg or MAP is >130 mmHg and there is not evidence of elevated ICP, then consider a modest reduction of BP '''(eg, MAP of 110 mm Hg or target BP of 160/90 mm Hg)''' using intermittent or continuous intravenous medications to control BP and clinically reexamine the patient every 15 min


			===AHA Aneurysmal Subarachnoid Hemorrhage BP Guidelines<ref>Bederson J. et al. Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association. Stroke. 2009;40:994-1025 [http://stroke.ahajournals.org/content/40/3/994.full.pdf PDF]</ref>===
			#To date, no well-controlled studies exist that answer whether blood pressure control in acute SAH influences rebreeding.
			#Blood pressure should be monitored and controlled to balance the risk of stroke, hypertension-related rebleeding, and maintenance of cerebral perfusion pressure (Class I, Level of Evidence B).
			#Nicardipine, labetalol, and esmolol are appropriate choices for blood pressure control. Sodium nitroprusside may raise intracranial pressure and cause toxicity with prolonged infusion and should be avoided.

Ostermayer: /* AHA Spontaneous ICH Blood Pressure GuidelinesMorgenstern, L. et al. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association Strok...

2014-05-14T16:40:03Z

← Older revision		Revision as of 16:40, 14 May 2014
Line 2:		Line 2:
	#If SBP is >200 mm Hg or MAP is >150 mm Hg, then consider aggressive reduction of BP with continuous intravenous infusion, with frequent BP monitoring every 5 min.		#If SBP is >200 mm Hg or MAP is >150 mm Hg, then consider aggressive reduction of BP with continuous intravenous infusion, with frequent BP monitoring every 5 min.
	#If SBP is >180 mmHg or MAP is >130mm Hg and there is the possibility of elevated ICP, then consider monitoring ICP and reducing BP using intermittent or continuous intravenous medications while maintaining a cerebral perfusion pressure ≥60 mm Hg		#If SBP is >180 mmHg or MAP is >130mm Hg and there is the possibility of elevated ICP, then consider monitoring ICP and reducing BP using intermittent or continuous intravenous medications while maintaining a cerebral perfusion pressure ≥60 mm Hg
	#If SBP is >180 mmHg or MAP is >130 mmHg and there is not evidence of elevated ICP, then consider a modest reduction of BP ''(eg, MAP of 110 mm Hg or target BP of 160/90 mm Hg)'' using intermittent or continuous intravenous medications to control BP and clinically reexamine the patient every 15 min		#If SBP is >180 mmHg or MAP is >130 mmHg and there is not evidence of elevated ICP, then consider a modest reduction of BP '''(eg, MAP of 110 mm Hg or target BP of 160/90 mm Hg)''' using intermittent or continuous intravenous medications to control BP and clinically reexamine the patient every 15 min

Ostermayer: /* AHA Spontaneous ICH Blood Pressure GuidelinesMorgenstern, L. et al. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association Strok...

2014-05-14T16:37:22Z

← Older revision		Revision as of 16:37, 14 May 2014
Line 2:		Line 2:
	#If SBP is >200 mm Hg or MAP is >150 mm Hg, then consider aggressive reduction of BP with continuous intravenous infusion, with frequent BP monitoring every 5 min.		#If SBP is >200 mm Hg or MAP is >150 mm Hg, then consider aggressive reduction of BP with continuous intravenous infusion, with frequent BP monitoring every 5 min.
	#If SBP is >180 mmHg or MAP is >130mm Hg and there is the possibility of elevated ICP, then consider monitoring ICP and reducing BP using intermittent or continuous intravenous medications while maintaining a cerebral perfusion pressure ≥60 mm Hg		#If SBP is >180 mmHg or MAP is >130mm Hg and there is the possibility of elevated ICP, then consider monitoring ICP and reducing BP using intermittent or continuous intravenous medications while maintaining a cerebral perfusion pressure ≥60 mm Hg
	#If SBP is >180 mmHg or MAP is >130 mmHg and there is not evidence of elevated ICP, then consider a modest reduction of BP (eg, MAP of 110 mm Hg or target BP of 160/90 mm Hg) using intermittent or continuous intravenous medications to control BP and clinically reexamine the patient every 15 min		#If SBP is >180 mmHg or MAP is >130 mmHg and there is not evidence of elevated ICP, then consider a modest reduction of BP ''(eg, MAP of 110 mm Hg or target BP of 160/90 mm Hg)'' using intermittent or continuous intravenous medications to control BP and clinically reexamine the patient every 15 min

Ostermayer: Ostermayer moved page ICH Hypertension Guidelines to Template:ICH Hypertension Guidelines without leaving a redirect

2014-05-13T16:30:59Z

Ostermayer moved page ICH Hypertension Guidelines to Template:ICH Hypertension Guidelines without leaving a redirect

← Older revision	Revision as of 16:30, 13 May 2014
(No difference)